𝔖 Bobbio Scriptorium
✦   LIBER   ✦

T cell activation by anti-CD3 antibodies: function of Fc receptors on B cell blasts, but not resting B cells, and CD18 on the responding T cells

✍ Scribed by Jonathan M. Austyn; Kenneth G. C. Smith; Peter J. Morris

Publisher
John Wiley and Sons
Year
1987
Tongue
English
Weight
724 KB
Volume
17
Category
Article
ISSN
0014-2980

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Anti-CD3-based bispecific antibody desig
Anti-CD3-based bispecific antibody designed for therapy of human B-cell malignancy can induce T-cell activation by antigen-dependent and antigen-independent mechanisms
✍ Brian K. Link; Sheri A. Kostelny; Michael S. Cole; William P. Fusselman; J. Yun πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 French βš– 107 KB πŸ‘ 2 views

## Anti -CD3 Ψ‹ anti-B-cell antigen bispecific monoclonal antibodies (bsAbs) can redirect T-cell-mediated lysis toward malignant B cells. Clinical trials with CD3-based bsAbs have shown toxicity in patients which is likely related to nonspecific T-cell activation and targeting. Our current studies

Effect of tetravalent bispecific CD19Γ—CD
Effect of tetravalent bispecific CD19Γ—CD3 recombinant antibody construct and CD28 costimulation on lysis of malignant B cells from patients with chronic lymphocytic leukemia by autologous T cells
✍ Uwe Reusch; Fabrice Le Gall; Manfred Hensel; Gerhard Moldenhauer; Anthony D. Ho; πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 French βš– 284 KB

## Abstract To develop an effective antitumor immunotherapy for B‐lineage non‐Hodgkin's lymphoma, we constructed a tetravalent tandem diabody (tanDb) specific for both human CD19 (B‐cell marker) and CD3 (T‐cell antigen). Here, we report the effective killing of malignant primary B cells from patien